Leon J. Thal - Concepedia

Author

Leon J. Thal

Also Known As

Andrew J. Saykin, Gus Jiminez, Kristi Wilmes, Kristin Harkins, Kwangsik Nho, L J Thal, LEON J. THAL, Laurel Beckett, Lean Thal, Leon J Thal

329

Publications

40.5K

Citations

H-Index

151

Concepts

All Affiliations

University of California San Diego Alzheimer’s Disease Neuroimaging Initiative Albert Einstein College of Medicine San Francisco VA Medical Center University of Southern California

About

Leon J. Thal is an author at University of California San Diego specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	85	7.2K
2	Health Sciences	19	22	1.2K
3	Natural Sciences	2	2	889
4	Engineering	1	1	149
5	Humanities	1	1	97

Leon J. Thal

166

Publications

26.1K

Citations

H-Index

Page 1

	Year	Citations
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease Mary Sano, Christopher Ernesto, Ronald G. Thomas, New England Journal of Medicine	1997	2.4K
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women Sally A. Shumaker, Claudine Legault, Stephen R. Rapp, JAMA	2003	2.2K
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment Ronald Petersen, Ronald G. Thomas, Michael Grundman, New England Journal of Medicine	2005	1.8K
Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI) Susanne G. Mueller, Michael W. Weiner, Leon J. Thal, Alzheimer s & Dementia	2005	1.2K
Epidermal Growth Factor and Fibroblast Growth Factor-2 Have Different Effects on Neural Progenitors in the Adult Rat Brain H. Georg Kuhn, Jürgen Winkler, Gerd Kempermann, Journal of Neuroscience	1997	1.2K
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease Mark H. Tuszynski, Leon J. Thal, Mary Pay, Nature Medicine Alzheimer's DiseaseDementiaExperimental NeuropathologyNeurochemical BiomarkersNeurology	2005	1K
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. Ruth A. Mulnard, Carl W. Cotman, Claudia H. Kawas, PubMed	2000	985
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. Paul Aisen, Kimberly Schafer, Michael Grundman, PubMed	2003	959
Proliferation and Differentiation of Progenitor Cells Throughout the Intact Adult Rat Spinal Cord Philip J. Horner, Ann E. Power, Gerd Kempermann, Journal of Neuroscience	2000	774
Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs Richard C. Mohs, David S. Knopman, Ronald C. Petersen, Alzheimer Disease & Associated Disorders Antidementia DrugsNeuropsychologyPsychotropic MedicationPsychopharmacologyCognition	1997	676

Page 1